Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Vaccine Study Center to lead effort searching medical records for serious reactions By Jan Greene New vaccines recently approved to protect against COVID-19 disease were developed at record speed. To support public confidence in the massive vaccination effort under way…
New study is first to quantify and compare the effects of long-term exposure to small particle pollution on risk for different types of cardiovascular disease.
Adolescents who had access to a brief intervention and referral to treatment for substance use or mood problems at a pediatric clinic were less likely to have a related diagnosis 3 years later, new Kaiser Permanente research finds.
Pregnant women who exercised more during the first trimester of pregnancy had a lower risk of developing gestational diabetes, a new analysis of Kaiser Permanente data finds.
The potential for statins — a widely prescribed class of cholesterol-lowering medication — to reduce the risk of Alzheimer’s disease and related dementias will be explored in a 4-year study led by Division of Research investigator Catherine Schaefer, PhD.
Four research fellows recently joined the Division of Research postdoc program, embarking on a unique pathway for career development.
A sophisticated system that analyzes electronic data about hospital patients, identifies those at risk of deteriorating, and issues an alert to a centralized team of specially trained nurses resulted in a lower mortality rate, Kaiser Permanente researchers reported in the New England Journal of Medicine.
Three Kaiser Permanente physicians have joined The Permanente Medical Group Physician Researcher Program, which allows them to continue their clinical work while pursuing specific research projects.
Kaiser Permanente research found a computerized alert that notifies health care providers when a prostate cancer screening test is not recommended improved adherence to PSA screening guidelines.
Researchers with Kaiser Permanente are launching a study using blood tests for antibodies to the SARS-CoV-2 virus to estimate the prevalence and incidence of COVID-19 disease in Northern California and explore whether antibodies confer protection from recurrent disease.